It is a research & development private limited company based in Bangalore, Karnataka, India, established in 2020.
2020 | Bangalore, Karnataka, India | ActiveSprygen Biotherapeutics Private Limited, a active private limited company, was established on 10 January 2020 in Bangalore, Karnataka, India. Engaging in research & development within the professional, scientific and technical sector, it holds CIN: U85100KA2020PTC131489. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Formerly known as Caartigen Biotherapeutics Private Limited. Its leadership includes Sujatha Shrinivas (Director), Natarajan Essakimuthu (Director). Its latest AGM occurred on 05 September 2024, with the balance sheet filed on 31 March 2024. It is based at No.677, 1St Floor, 27Th Main, 13Th Cross Sector 1, Hsr Layout, Bangalore, Karnataka, 560102.
U85100KA2020PTC131489
131489
10 January 2020
₹0.10 M
₹0.10 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Sprygen Biotherapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sujatha Shrinivas | Director | 10 Jan 2020 | Current |
| Natarajan Essakimuthu | Director | 10 Jan 2020 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sprygen Biotherapeutics Private Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 58.68% increase in profit. The company's net worth observed a substantial decline by a decrease of 25%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Sprygen Biotherapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Sprygen Biotherapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sprygen Biotherapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sprygen Biotherapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Sprygen Biotherapeutics Private Limited last Annual general meeting of members was held on 05 Sep 2024 as per latest MCA records. was recorded as a recent event.
Sprygen Biotherapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was recorded as a recent event.
The activity Sujatha Shrinivas was appointed as a Director was appointed as a Director on 10 Jan 2020 & has been associated with this company since 5 years 11 months . was completed.
The activity Natarajan Essakimuthu was appointed as a Director was appointed as a Director on 10 Jan 2020 & has been associated with this company since 5 years 11 months . was completed.
Sprygen Biotherapeutics Private Limited was registered on 10 Jan 2020 with Roc Bangalore & aged 5 years 11 months as per MCA records. was recorded as a recent event.
The CIN of Sprygen Biotherapeutics Private Limited is U85100KA2020PTC131489.
Sprygen Biotherapeutics Private Limited is headquartered at No.677, 1St Floor, 27Th Main, 13Th Cross Sector 1, Hsr Layout, Bangalore, Karnataka, 560102.
Sprygen Biotherapeutics Private Limited was incorporated on 10 January 2020.
The current directors of Sprygen Biotherapeutics Private Limited are
The primary industry of Sprygen Biotherapeutics Private Limited is Professional, Scientific And Technical.
Sprygen Biotherapeutics Private Limited is unlisted.
The authorized capital of Sprygen Biotherapeutics Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX